Munver R, Schulman I C, Wolf D J, Rosengart T K
New York Hospital-Cornell University Medical College, New York 10021.
Ann Thorac Surg. 1994 Dec;58(6):1764-6. doi: 10.1016/0003-4975(94)91686-1.
Heparin-induced thrombocytopenia and thrombosis syndrome was diagnosed in a 63-year-old woman 11 days after coronary artery bypass grafting. Her only presenting complaints were incisional leg pain and vague chest discomfort. The syndrome was suspected when her platelet count was found to be 37,000/microL. A subsequent ventilation-perfusion lung scan showed findings highly probable for pulmonary embolism. An inferior venacavogram obtained before a pulmonary angiogram revealed a large retrohepatic thrombus at the right atrial junction. The patient was successfully treated with the defibrinogenating agent ancrod (Arvin). A diagnosis of heparin-induced thrombocytopenia and thrombosis syndrome should be considered and heparin therapy should be avoided in patients with low platelet counts who have been previously treated with heparin.
一名63岁女性在冠状动脉搭桥术后11天被诊断为肝素诱导的血小板减少和血栓形成综合征。她唯一的主诉是腿部切口疼痛和胸部隐约不适。当发现她的血小板计数为37,000/微升时,怀疑出现了该综合征。随后的通气-灌注肺扫描显示肺栓塞的可能性很大。在进行肺血管造影之前进行的下腔静脉造影显示,在右心房交界处有一个巨大的肝后血栓。该患者用去纤维蛋白原制剂安克洛酶(Arvin)成功治疗。对于曾接受肝素治疗且血小板计数低的患者,应考虑诊断为肝素诱导的血小板减少和血栓形成综合征,并应避免肝素治疗。